Alphabet buys Intersect for billions to expand data center capacity. The deal sparks debate about energy consumption, costs, and public health risks related to data center growth.
posted on 12/23/2025
Isomorphic Labs, backed by Google's parent Alphabet, is set to begin human trials for cancer drugs designed entirely by AI, marking a pivotal moment in medicine.
posted on 07/09/2025
Alphabet CEO Sundar Pichai addresses concerns about AI replacing jobs, highlighting AI's role in boosting productivity and driving growth.
posted on 06/05/2025